Graphite Bio, Inc. (GRPH) Social Stream
GRAPHITE BIO INC (GRPH) Price Targets From Analysts
Use the tables below to see what analysts covering GRAPHITE BIO INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 4 | $35 | $34 | $34.666 | $2.62 | 1223.13% |
| 2022-01-28 | 4 | $35 | $30 | $33 | $2.62 | 1159.54% |
| 2022-01-31 | 4 | $34 | $19 | $27.666 | $2.62 | 955.95% |
| 2022-02-18 | 5 | $34 | $11 | $23.5 | $2.62 | 796.95% |
| 2022-03-21 | 5 | $30 | $8 | $16.75 | $2.62 | 539.31% |
| 2022-04-13 | 5 | $24 | $8 | $15.25 | $2.62 | 482.06% |
| 2022-04-14 | 6 | $24 | $8 | $15.8 | $2.62 | 503.05% |
| 2022-05-16 | 6 | $18 | $8 | $13 | $2.62 | 396.18% |
| 2022-06-17 | 7 | $18 | $8 | $12.833 | $2.62 | 389.81% |
| 2022-07-15 | 5 | $18 | $6 | $12.5 | $2.62 | 377.1% |
| 2022-08-12 | 6 | $18 | $6 | $12.5 | $2.62 | 377.1% |
| 2022-08-13 | 7 | $18 | $6 | $12.5 | $2.62 | 377.1% |
| 2022-10-12 | 8 | $18 | $6 | $12.428 | $2.62 | 374.35% |
| 2022-10-24 | 8 | $18 | $6 | $11.571 | $2.62 | 341.64% |
| 2022-11-10 | 8 | $18 | $6 | $11.714 | $2.62 | 347.1% |
| 2022-11-13 | 8 | $18 | $6 | $11.428 | $2.62 | 336.18% |
| 2022-12-23 | 8 | $18 | $6 | $11.142 | $2.62 | 325.27% |
| 2023-01-06 | 8 | $18 | $2 | $7.428 | $2.62 | 183.51% |
| 2023-01-17 | 8 | $18 | $2 | $7.428 | $2.62 | 183.51% |
| 2023-01-23 | 8 | $18 | $2 | $6.857 | $2.62 | 161.72% |
| 2023-01-26 | 8 | $18 | $2 | $6.857 | $2.62 | 161.72% |
| 2023-02-08 | 7 | $18 | $2 | $6.428 | $2.62 | 145.34% |
| 2023-02-26 | 7 | $18 | $2 | $5.714 | $2.62 | 118.09% |
| 2023-03-21 | 8 | $18 | $2 | $5.714 | $2.62 | 118.09% |
| 2023-04-12 | 8 | $18 | $2 | $5.571 | $2.62 | 112.63% |
| 2023-09-01 | 8 | $7 | $2 | $3.5 | $2.62 | 33.59% |
| 2023-11-13 | 6 | $7 | $2 | $3.75 | $2.62 | 43.13% |
| 2023-12-15 | 3 | $3 | $3 | $3 | $2.62 | 14.5% |
The Trend in the Analyst Price Target
Over the past 49 weeks, GRPH's average price target has gone down $4.43.
Over the past 49 weeks, GRPH's average upside potential has been 105.3%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 8 | 18 | 2 | 6.857 | 1.93 | 255.28% |
| 2023-02-08 | 7 | 18 | 2 | 6.428 | 2.22 | 189.55% |
| 2023-03-21 | 8 | 18 | 2 | 5.714 | 2.33 | 145.24% |
| 2023-04-12 | 8 | 7 | 2 | 3.500 | 2.47 | 41.7% |
| 2023-09-01 | 6 | 7 | 2 | 3.600 | 2.25 | 60% |
GRPH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 3 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
GRPH's average broker recommendation rating worsened by 1.5 over the prior 26 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GRPH as an investment opportunity.
- GRPH has a lower variance in analysts' estimates than -2978.54% of all US stocks.
- GRAPHITE BIO INC's upside potential (average analyst target price relative to current price) is greater than 3194.18% of all US stocks.
- In terms of how GRAPHITE BIO INC fares relative to all US stocks, note that its average analyst price target is higher than 499.7% of that group.
- In terms of how GRAPHITE BIO INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 2593.78% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to GRAPHITE BIO INC are ABOS, CADL, and TNYA.
View All Top Stocks by Price Target
Is GRPH a Buy, Hold or Sell? See the POWR Ratings now!